LYPD3 Protein (AA 33-287) (His tag)
Quick Overview for LYPD3 Protein (AA 33-287) (His tag) (ABIN7275200)
Target
Protein Type
Biological Activity
Origin
Source
Purity
-
-
Protein Characteristics
- AA 33-287
-
Purification tag / Conjugate
- This LYPD3 protein is labelled with His tag.
-
Purpose
- Mouse LYPD3 Protein
-
Sequence
- Leu33-His287
-
Characteristics
- Recombinant Mouse LYPD3 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Leu33-His287.
-
Sterility
- 0.22 μm filtered
-
Endotoxin Level
- Less than 1 EU per μg by the LAL method.
-
Biological Activity Comment
- Mouse LYPD3 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Dissolve the lyophilized protein in distilled water. It is recommended to resuspend at 0.5 mg/mL if the lyophilized powder is 100 μg or less, at 1 mg/mL for 500 μg or 1 mg lyophilized powder. Do not mix by vortex or vigorous shaking.
-
Buffer
- Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3 months after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- LYPD3 (LY6/PLAUR Domain Containing 3 (LYPD3))
-
Alternative Name
- LYPD3
-
Background
- Aberrant expression of LYPD3 plays an oncogenic role in several types of cancer.LYPD3 was able to be regulated by the methylation in LYPD3 promoter region, which was positively associated with the overall survival. Furthermore, we explored the related pathways through which LYPD3 affects the pathogenesis and prognosis of LUAD by gene set enrichment analysis, and found that LYPD3 might affect the clinical manifestations of LUAD by regulating the P53 signaling pathway.
-
Molecular Weight
- 27.6 kDa. Due to glycosylation, the protein migrates to 70-80 kDa based on Bis-Tris PAGE result.
-
UniProt
- Q91YK8
Target
-